Sartorius (OTCMKTS:SARTF) Shares Gap Up - Time to Buy?

Key Points

• Sartorius stock gapped up from a previous closing price of $187.87 to open at $201.69 on Tuesday, with a trading volume of only 10 shares.
• Jefferies Financial Group has upgraded Sartorius to a "strong-buy" rating, contributing to an overall analyst average rating of "Strong Buy."
• Despite reporting a quarterly EPS of $1.38, Sartorius missed analysts' expectations of $1.49 by $0.11, although it generated $1.04 billion in revenue, exceeding estimates.

Sartorius (OTCMKTS:SARTF - Get Free Report)'s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $187.87, but opened at $201.69. Sartorius shares last traded at $201.69, with a volume of 10 shares changing hands.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised Sartorius to a "strong-buy" rating in a research report on Tuesday, August 12th. Three research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Strong Buy".

Sartorius Stock Performance

The company has a quick ratio of 0.88, a current ratio of 1.39 and a debt-to-equity ratio of 1.08. The stock has a 50 day simple moving average of $189.57 and a 200 day simple moving average of $192.99. The company has a market capitalization of $6.90 billion, a price-to-earnings ratio of 122.98 and a beta of 1.00.

Sartorius (OTCMKTS:SARTF - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The company reported $1.38 EPS for the quarter, missing analysts' consensus estimates of $1.49 by ($0.11). Sartorius had a net margin of 3.00% and a return on equity of 7.79%. The company had revenue of $1.04 billion during the quarter, compared to analyst estimates of $977.90 million.

Sartorius Company Profile

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.